Skip to main content
SpringerLink
Log in

Akinetic mutism—a serious complication to tacrolimus-based GVHD prophylaxis

  • Letter to the Editor
  • Published:
Bone Marrow Transplantation Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Lee T, Kennedy L . Tacrolimus: an alternative for graft-versus-host disease prevention. Ann Pharmacother 2000; 34: 377–381.

    Article  CAS  Google Scholar 

  2. Bechstein WO . Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transpl Int 2000; 13: 313–326.

    Article  CAS  Google Scholar 

  3. Sokol DK, Molleston J, Filo RS, Van Valer J, Edwards-Brown M . Tacrolimus induced mutism after liver transplant. Pediatr Neurol 2003; 28: 156–158.

    Article  Google Scholar 

  4. Bronster D, Gurkan A, Buchsbaum M, Sukru E . Tacrolimus-associated mutism after orthotopic liver transplantation. Transplantation 2000; 70: 979–982.

    Article  CAS  Google Scholar 

  5. Boeve B, Kimmel D, Aronson A, De Groen P . Dysarthria and apraxia of speech associated with FK-506. Mayo Clin Oric 1996; 71: 969–972.

    Article  CAS  Google Scholar 

  6. Odonnell M, Williams J, Weinrieb R, Denysenko L . Catatonic mutism after liver transplant rapidly reversed with lorazepam. Gen Hosp Psychiatry 2007; 29: 280–281.

    Article  Google Scholar 

  7. Sierra F, Matinez A, Moreno S, de Pablo F, Correas E, Ruiz J . Akinetic mutism induced by tracrolimus. Clin Neuropharm 2009; 32: 293–294.

    Article  Google Scholar 

  8. Vearrier D, Simpson SE, Greenberg M . Mutism and persistent dysarthria due to tacrolimus-based immunosupression following allogenic liver transplantation. Am J Ther 2010; 18: e274–e2766.

    Article  Google Scholar 

  9. Ahn K, Lee JW, Hahn ST, Yang DW, Kim PS, Kim HJ et al. Diffusion weighted MRI and ADC mapping in FK506 neurotoxicity. Br J Radiol 2003; 76: 916–919.

    Article  CAS  Google Scholar 

  10. Chohan R, Vij R, Adkins D, Blum W, Brown R, Tomasson M et al. Long term outcomes of allogenic stem cell transplant recipients after calcineurin inhibitor-induced neurotoxicity. Br J Haematol 2003; 123: 110–113.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology/Oncology, MD Anderson Cancer Center, Orlando, Orlando, FL, USA

    J E Najera

  2. Department of Internal Medicine, University of Central Florida, College of Medicine, Orlando, FL, USA

    J E Najera

  3. The University of Texas, MD Anderson Cancer Center, Stem Cell Transplantation & Cellular Therapy, Orlando, FL, USA

    A Alousi, M De Lima & S O Ciurea

Authors
  1. J E Najera
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Alousi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M De Lima
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S O Ciurea
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J E Najera.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Najera, J., Alousi, A., De Lima, M. et al. Akinetic mutism—a serious complication to tacrolimus-based GVHD prophylaxis. Bone Marrow Transplant 48, 157–158 (2013). https://doi.org/10.1038/bmt.2012.110

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2012.110

  • Springer Nature Limited

This article is cited by

Search

Navigation